Indranil Sinha1,2, Andrea L Pusic1,2, Edwin G Wilkins1,2, Jennifer B Hamill1,2, Xiaoxue Chen1,2, Hyungjin M Kim1,2, Gretchen Guldbrandsen1,2, Yoon S Chun1,2. 1. Boston, Mass.; New York, N.Y.; and Ann Arbor, Mich. 2. From the Division of Plastic Surgery, Brigham and Women's Hospital; the Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center; and the Section of Plastic Surgery and the Center for Statistical Consultation and Research, University of Michigan.
Abstract
BACKGROUND: Surgical-site infection causes devastating reconstructive failure in implant-based breast reconstructions. Large national database studies offer insights into complication rates, but only capture outcomes within 30 days postoperatively. This study evaluates both early and late surgical-site infection in immediate implant-based reconstruction and identifies predictors. METHODS: As part of the Mastectomy Reconstruction Outcomes Consortium Study, 1662 implant-based breast reconstructions in 1024 patients were evaluated for early versus late surgical-site infection. Early surgical-site infection was defined as infection occurring within 30 days postoperatively; late surgical-site infection was defined as infection occurring 31 days to 1 year postoperatively. Minor infection required oral antibiotics only, and major infection required hospitalization and/or surgical treatment. Direct-to-implant patients had 1-year follow-up, and tissue expander patients had 1-year post-exchange follow-up. RESULTS: Among 1491 tissue expander and 171 direct-to-implant reconstructions, overall surgical-site infection rate for tissue expander was 5.7 percent (85 of 1491) after first-stage, 2.5 percent (31 of 1266) after second-stage, and 9.9 percent (17 of 171) for direct-to-implant reconstruction. Over 47 to 71 percent of surgical-site infection complications were late surgical-site infection. Multivariate analysis identified radiotherapy and increasing body mass index as significant predictors of late surgical-site infection. No significant difference between the direct-to-implant and tissue expander groups in the occurrence of early, late, or overall surgical-site infection was found. CONCLUSIONS: The majority of surgical-site infection complications in immediate implant-based breast reconstructions occur more than 30 days after both first-stage and second-stage procedures. Radiotherapy and obesity are significantly associated with late-onset surgical-site infection. Current studies limited to early complications do not present a complete assessment of infection associated with implant-based breast reconstructions or their long-term clinical outcomes. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, II.
BACKGROUND: Surgical-site infection causes devastating reconstructive failure in implant-based breast reconstructions. Large national database studies offer insights into complication rates, but only capture outcomes within 30 days postoperatively. This study evaluates both early and late surgical-site infection in immediate implant-based reconstruction and identifies predictors. METHODS: As part of the Mastectomy Reconstruction Outcomes Consortium Study, 1662 implant-based breast reconstructions in 1024 patients were evaluated for early versus late surgical-site infection. Early surgical-site infection was defined as infection occurring within 30 days postoperatively; late surgical-site infection was defined as infection occurring 31 days to 1 year postoperatively. Minor infection required oral antibiotics only, and major infection required hospitalization and/or surgical treatment. Direct-to-implant patients had 1-year follow-up, and tissue expander patients had 1-year post-exchange follow-up. RESULTS: Among 1491 tissue expander and 171 direct-to-implant reconstructions, overall surgical-site infection rate for tissue expander was 5.7 percent (85 of 1491) after first-stage, 2.5 percent (31 of 1266) after second-stage, and 9.9 percent (17 of 171) for direct-to-implant reconstruction. Over 47 to 71 percent of surgical-site infection complications were late surgical-site infection. Multivariate analysis identified radiotherapy and increasing body mass index as significant predictors of late surgical-site infection. No significant difference between the direct-to-implant and tissue expander groups in the occurrence of early, late, or overall surgical-site infection was found. CONCLUSIONS: The majority of surgical-site infection complications in immediate implant-based breast reconstructions occur more than 30 days after both first-stage and second-stage procedures. Radiotherapy and obesity are significantly associated with late-onset surgical-site infection. Current studies limited to early complications do not present a complete assessment of infection associated with implant-based breast reconstructions or their long-term clinical outcomes. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, II.
Authors: Carla Renata Arciola; Davide Campoccia; Pietro Speziale; Lucio Montanaro; John William Costerton Journal: Biomaterials Date: 2012-06-12 Impact factor: 12.479
Authors: Nima Khavanin; Karol A Gutowski; Keith M Hume; Christopher J Simmons; Alexei S Mlodinow; Michael Weiss; Kristen E Mayer; Robert X Murphy; John Y S Kim Journal: Ann Plast Surg Date: 2015-02 Impact factor: 1.539
Authors: Dujata Saha; Armando A Davila; Jon P Ver Halen; Umang K Jain; Nora Hansen; Kevin Bethke; Seema A Khan; Jacqueline Jeruss; Neil Fine; john Y S Kim Journal: Breast Date: 2013-12 Impact factor: 4.380
Authors: Michael S Gart; John T Smetona; Philip J Hanwright; Neil A Fine; Kevin P Bethke; Seema A Khan; Edward Wang; John Y S Kim Journal: J Am Coll Surg Date: 2012-12-02 Impact factor: 6.113
Authors: Adeyiza O Momoh; Raouf Ahmed; Brian P Kelley; Oluseyi Aliu; Kelley M Kidwell; Jeffrey H Kozlow; Kevin C Chung Journal: Ann Surg Oncol Date: 2013-10-01 Impact factor: 5.344
Authors: Reshma Jagsi; Adeyiza O Momoh; Ji Qi; Jennifer B Hamill; Jessica Billig; Hyungjin M Kim; Andrea L Pusic; Edwin G Wilkins Journal: J Natl Cancer Inst Date: 2018-02-01 Impact factor: 13.506
Authors: Austin D Chen; Parisa Kamali; Anmol S Chattha; Alexandra Bucknor; Justin B Cohen; Patrick P Bletsis; Renata Flecha-Hirsch; Adam M Tobias; Bernard T Lee; Samuel J Lin Journal: Plast Reconstr Surg Glob Open Date: 2018-03-06
Authors: Jordan T Blough; Michael M Vu; Cecil S Qiu; Alexei S Mlodinow; Nima Khavanin; Neil A Fine; John Y S Kim Journal: Plast Reconstr Surg Glob Open Date: 2018-12-12